DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,745,591 | -2.9% | 27,189 | -6.1% | 0.35% | +3.6% |
| Q2 2023 | $6,946,080 | -6.0% | 28,942 | -1.3% | 0.34% | -10.8% |
| Q1 2023 | $7,389,308 | -23.4% | 29,318 | -19.4% | 0.38% | -12.3% |
| Q4 2022 | $9,649,875 | -1.8% | 36,357 | -4.4% | 0.43% | -10.6% |
| Q3 2022 | $9,824,577 | +1.8% | 38,037 | -0.0% | 0.48% | +14.2% |
| Q2 2022 | $9,646,436 | -14.3% | 38,050 | -0.8% | 0.42% | +5.5% |
| Q1 2022 | $11,252,725 | -53.3% | 38,362 | -47.7% | 0.40% | +22.3% |
| Q4 2021 | $24,117,749 | +5.2% | 73,304 | -2.7% | 0.33% | -1.2% |
| Q3 2021 | $22,932,856 | +9.8% | 75,328 | -3.3% | 0.33% | +12.9% |
| Q2 2021 | $20,894,241 | +20.4% | 77,859 | +1.0% | 0.29% | +13.5% |
| Q1 2021 | $17,350,517 | -3.3% | 77,086 | -4.5% | 0.26% | -3.4% |
| Q4 2020 | $17,937,805 | -1.8% | 80,750 | -4.8% | 0.27% | -16.0% |
| Q3 2020 | $18,273,550 | +16.9% | 84,863 | -4.0% | 0.32% | +15.2% |
| Q2 2020 | $15,634,071 | +17.0% | 88,413 | -8.4% | 0.28% | -2.1% |
| Q1 2020 | $13,357,395 | -10.2% | 96,506 | -0.5% | 0.28% | +14.6% |
| Q4 2019 | $14,879,272 | +5.8% | 96,946 | -0.4% | 0.25% | +3.8% |
| Q3 2019 | $14,061,705 | +4.5% | 97,360 | +3.4% | 0.24% | +4.8% |
| Q2 2019 | $13,450,916 | +16.9% | 94,115 | +8.0% | 0.23% | +9.1% |
| Q1 2019 | $11,502,771 | +25.8% | 87,129 | -1.8% | 0.21% | +13.7% |
| Q4 2018 | $9,146,950 | -6.3% | 88,702 | -1.3% | 0.18% | +5.2% |
| Q3 2018 | $9,766,795 | -99.9% | 89,884 | -3.5% | 0.17% | +16.8% |
| Q2 2018 | $9,190,067,000 | -1.9% | 93,130 | -2.6% | 0.15% | +12.9% |
| Q1 2018 | $9,365,582,000 | +106266.6% | 95,655 | +0.8% | 0.13% | +12.8% |
| Q4 2017 | $8,805,000 | -64.5% | 94,860 | -67.2% | 0.12% | -24.5% |
| Q3 2017 | $24,819,000 | -0.1% | 289,331 | -1.7% | 0.16% | -9.9% |
| Q2 2017 | $24,851,000 | -5.8% | 294,476 | -4.5% | 0.17% | -6.0% |
| Q1 2017 | $26,368,000 | +8.5% | 308,290 | -1.3% | 0.18% | +4.6% |
| Q4 2016 | $24,303,000 | -2.9% | 312,219 | -2.2% | 0.18% | -4.4% |
| Q3 2016 | $25,028,000 | -22.0% | 319,281 | +0.4% | 0.18% | -23.1% |
| Q2 2016 | $32,106,000 | +6.4% | 317,885 | -0.0% | 0.24% | +2.6% |
| Q1 2016 | $30,165,000 | +0.7% | 317,999 | -1.4% | 0.23% | +0.9% |
| Q4 2015 | $29,950,000 | +7.3% | 322,456 | -1.5% | 0.23% | +14.4% |
| Q3 2015 | $27,900,000 | -5.6% | 327,426 | -5.2% | 0.20% | -3.4% |
| Q2 2015 | $29,552,000 | +0.7% | 345,277 | -0.1% | 0.21% | -3.7% |
| Q1 2015 | $29,334,000 | -1.8% | 345,514 | -0.9% | 0.22% | +4.3% |
| Q4 2014 | $29,877,000 | +13.6% | 348,586 | +0.7% | 0.21% | +9.5% |
| Q3 2014 | $26,292,000 | -3.8% | 346,045 | -0.3% | 0.19% | -0.5% |
| Q2 2014 | $27,321,000 | +0.6% | 347,021 | -4.2% | 0.19% | +1.1% |
| Q1 2014 | $27,159,000 | -4.2% | 362,125 | -1.4% | 0.19% | -5.5% |
| Q4 2013 | $28,361,000 | +8.3% | 367,374 | -2.7% | 0.20% | -0.5% |
| Q3 2013 | $26,179,000 | +11.7% | 377,648 | +2.0% | 0.20% | +7.0% |
| Q2 2013 | $23,427,000 | – | 370,095 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |